Date Filed | Type | Description |
08/10/2023 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Sold 4,741 shares
@ $105, valued at
$497.8k
Sold 244 shares
@ $105.43, valued at
$25.7k
Sold 15 shares
@ $107.42, valued at
$1.6k
Sold 5,112 shares
@ $105, valued at
$536.8k
Sold 272 shares
@ $105.43, valued at
$28.7k
Sold 16 shares
@ $107.42, valued at
$1.7k
Exercised 5,000 options to buy
@ $38.4, valued at
$192k
|
|
08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/03/2023 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Sold 8,226 shares
@ $110.5607, valued at
$909.5k
Exercised 8,226 options to buy
@ $47, valued at
$386.6k
|
|
05/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/02/2023 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Paid exercise price by delivering 7,531 shares
@ $99.77, valued at
$751.4k
Sold 679 shares
@ $100.7, valued at
$68.4k
|
|
02/22/2023 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Granted 18,233 shares
@ $0 Granted 71,907 options to buy
@ $106.24, valued at
$7.6M
|
|
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Granted 18,972 shares
@ $0 Granted 88,418 options to buy
@ $117.58, valued at
$10.4M
|
|
12/28/2021 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Sold 13,000 shares
@ $140, valued at
$1.8M
Sold 3,000 shares
@ $142.5, valued at
$427.5k
Exercised 3,000 options to buy
@ $47, valued at
$141k
Exercised 10,000 options to buy
@ $38.4, valued at
$384k
Exercised 3,000 options to buy
@ $47, valued at
$141k
|
|
12/21/2021 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Sold 7,500 shares
@ $137.54, valued at
$1M
Exercised 7,500 options to buy
@ $47, valued at
$352.5k
|
|
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2021 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Sold 12,500 shares
@ $130.0089, valued at
$1.6M
Exercised 5,000 options to buy
@ $47, valued at
$235k
Exercised 7,500 options to buy
@ $38.4, valued at
$288k
|
|
09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/05/2020 |
4
| Wainer Andrea F (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Paid exercise price by delivering 1,768 shares
@ $92.62, valued at
$163.8k
|
|
03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/05/2019 |
4
| Wainer Andrea F (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES
Txns:
| Granted 11,967 shares
@ $0 Granted 62,725 options to buy
@ $76.12, valued at
$4.8M
|
|
06/05/2019 |
3
| Wainer Andrea F (Executive Vice President) has filed a Form 3 on ABBOTT LABORATORIES |